Moorfields Eye Hospital Dubai unlocks the secrets to younger eyes this summer

[:en]2 June 2013 (Dubai, United Arab Emirates): Beauty is in the eye of the beholder and when it comes to anti-aging, cosmetic facial surgery around the eyes (‘periorbital rejuvenation’ as it is known to the experts) is the most common procedure. But results can be erratic with low patient satisfaction.  The best results are achieved when patients are operated on by Oculoplastic Surgeons who regularly operate on the eyelid and periorbital region, say the Consultant Oculoplastic Surgeons at Moorfields Eye Hospital Dubai, the first overseas branch of the world renowned Moorfields Eye Hospital in London.
The most common procedure in facial cosmetic surgery is performed on the upper and lower eyelids – ‘blepharoplasty’. Around 250,000 procedures are performed every year around the world. However, whilst it is a common procedure, the results can vary significantly from patient expectations.   “Traditional Blepharoplasty has an enormous potential for disaster,” says Dr Andrea Sciscio, Consultant Oculoplastic Surgeon at Moorfields Eye Hospital Dubai. “There is no perfect aesthetic procedure and it is very much a case of understanding each patient’s exact problem and address it accordingly.”
Blepharoplasty has evolved enormously since it was first developed 70 years ago.  Over the decades, the techniques have developed to yield the best aesthetic outcome for each patient individually. The eyelids have to be evaluated in the context of the eyebrow and the mid-face appearance – its overall ‘height’ and structure, adds Dr Qasiem Nasser, Consultant Oculoplastic Surgeon at Moorfields Eye Hospital Dubai: “An analysis of the soft tissues from the eyebrows to the mid-face, and from the surface to the deeper structures up to the orbital rim (eye socket and surrounding structure), allows the surgeon to establish the aging changes that have occurred with the patient and helps direct the blepharoplasty surgery to deliver the optimal aesthetic outcome.”

From June-August 2013, Moorfields Eye Hospital Dubai is offering a special summer rate on consultations for aesthetic eye surgery.

Moorfields Eye Hospital Dubai first colour vision study of the UAE’s diabetic population shows that ‘colour blindness’ is not a black and white issue

[:en]
10 June 2013 (Dubai, United Arab Emirates):  Moorfields Eye Hospital Dubai has revealed some of the findings of its first UAE colour vison study, undertaken by specialists from the hospital amongst people with diabetes in the UAE population. One of the unexpected findings was that significant colour vision defects were revealed in the vast majority of the tested Emirati population, which includes local people with and without diabetes. The general causes of ‘colour blindness’ (colour vision defects) are well known but the Moorfields study findings need more research to asses whether this UAE revelation is due to genetic or acquired factors (such as excessive exposure to sunlight or Vitamin D deficiency), according to the team at Moorfields.
What is commonly referred to as ‘colour blindness’ is not blindness at all but rather a colour vision deficiency – an inability or decreased ability to see colour or perceive colour differences under normal lighting conditions.
The first scientific paper on colour ‘blindness’ was published by an English chemist – John Dalton – in 1798, when he realised that he was colour blind. The paper was titled ‘Extraordinary facts relating to the vision of colours’.
Color blindness affects a significant number of people and especially isolated communities with a restricted gene pool. More than 95 percent of all variations in human colour vision involve the red and green receptors in male eyes and it is very rare for males or females to be ‘blind’ to the blue end of the spectrum.
An Ishihara colour test consisting of a series of pictures of coloured spots, is the test most often used to diagnose red–green colour deficiencies, with a shape or number embedded in the picture and which can be seen with normal colour vision but not with a colour defect.
The cause of colour blindness is now well known and understood and is related to a fault in the development of one or more sets of retinal ‘cones’ that perceive colour in light and transmit that information to the optic nerve. It is more common amongst men than women because it is linked to the genes, although eye or brain damage can also produce similar symptoms.
‘Colour blindness’ can be stationary or progressive in nature and can be linked to other eye conditions such as age related macular degeneration. It can be total (much less common) or partial and there are two major types of colour blindness: difficulty distinguishing between red and green, difficulty distinguishing between blue and yellow. Around 8 percent of males but only 0.5 percent of females are colour blind in some way or another.
One of the Moorfields researchers, Dr Imran Ansari – an Ophthalmologist at Moorfields Eye Hospital Dubai – comments: “There are different forms of ‘colour blindness’ which may have a variety of long term lifestyle implications as there is no cure. The condition may be acquired or inherited (congenital). It is usually classed as a mild disability and whilst it can be debilitating to some degree, there are also some situations where it can actually be an advantage, such as penetrating certain colour camouflages. Of course, there are some occupations in which ‘colour blindness’ is a distinct disadvantage, where recognising colour codes could be an important safety factor, such as when driving cars or flying aircraft, for example.”

Moorfields Eye Hospital Dubai appoints Consultant Paediatric Ophthalmologist to its permanent team of specialist consultants

7 July 2013 (Dubai, United Arab Emirates): Moorfields Eye Hospital Dubai, the first overseas branch of the world renowned Moorfields Eye Hospital in London, has announced the appointment of its latest specialist consultant to its growing team of medical specialists based permanently in Dubai. Dr Darakhshanda Khurram is a Consultant Paediatric Ophthalmologist with a specialist interest in paediatric cataract congenital eye disease  and squint (strabismus) surgery. Dr Khurram joins the hospital as Moorfields continues to increase its medical staff and strengthen its range of specialities, serving patients in the UAE and wider region, after operating in the Middle East for more than five years.
Dr Darakhshanda Khurram trained at Great Ormond Street Hospital and Moorfields Eye Hospital, in London, as a general ophthalmologist with a highly advanced sub-specialist interest in Paediatric Ophthalmology. Dr Khurram’s areas of expertise are the clinical and surgical management of congenital cataracts, congenital glaucoma and strabismus surgery (including the use of botulinum toxin ). She is very experienced in the screening and management of Retinopathy of Prematurity (ROP – a disease of the eye effecting prematurely born babies). She has advanced diagnostic skills in paediatric ophthalmology including congenital eye abnormalities and inherited diseases.
After studying medicine at the Rawalpindi Medical College, Pakistan, Dr Khurram completed a four-year ophthalmology residency programme leading to her post-graduate fellowship from the Royal College of Surgeons in Glasgow, UK. She trained and worked as an Assistant Professor at the Al-Shifa Eye Hospital in Pakistan, providing specialised paediatric ophthalmology services.
She completed her advanced fellowship training in Paediatric Ophthalmology and Strabismus at the two world renowned hospitals – Great Ormond Street Hospital and Moorfields Eye Hospital, in London, UK, where she worked with some of the most prominent Paediatric Ophthalmologists and built on her previous substantial experience to gain an in depth  and comprehensive knowledge of rare and challenging paediatric ophthalmic conditions as well as experience in the most modern surgical and clinical procedures.
Dr. Khurram has been an active researcher and has a strong record of peer reviewed publications in clinical research and audit. She has also presented at international conferences, including the American Association of Paediatric Ophthalmology and Strabismus, World Congress of Paediatric Ophthalmology and Strabismus, and World Ophthalmology Congress.
Commenting on the latest consultant appointment, Dr Clare Roberts, Medical Director at Moorfields Eye Hospital Dubai and herself a paediatric ophthalmologist, said: “We are delighted to welcome Dr Khurram to our growing team of specialists in Dubai and she brings with her outstanding qualifications and experience. Many of our consultants, like Dr Khurram, trained at Moorfields in London, and all are based permanently in the UAE to ensure a consistently high quality of continuity if patient care and follow up. We continue to see a growing number of children at the hospital and so her specialist skills in this area will be of particular value and we plan to appoint further specialists through the course of 2013.”
Moorfields Eye Hospital Dubai opened in 2007 and has since treated more than 26,000 patients.

Moorfields Eye Hospital Dubai supports 15th Emirates Ophthalmology Congress in Dubai (12-14 December 2013) with the participation of leading consultants

[:en]10 December 2013 (Dubai, United Arab Emirates): Moorfields Eye Hospital Dubai (Moorfields) will support the 15th Emirates Ophthalmology Congress in Dubai, with the active participation of some of its leading consultants who will moderate and present at the event. The annual congress will focus on updates and innovations in ophthalmology and will attract the leading practitioners in the field from the UAE, Middle East and other countries, including the full 10-strong team of ophthalmology consultants and other members of the clinical team at Moorfields Eye Hospital Dubai.
The 2013 Emirates Ophthalmology Congress meeting will be a forum for the latest advances, reviews of current theory and practice, and hands-on problem-based learning. Participants will gain insights into the most effective advances in the diagnosis and management of eye disease and prevention of blindness. Subspecialty sessions will cover the topics of Retina, Glaucoma, Cataract and Refractive surgery. A comprehensive poster program will be featured and will be digitally available at all times.
Dr Avinash Gurbaxani, Consultant Ophthalmic Surgeon in Uveitis and Medical Retinal Diseases at Moorfields, will speak at the symposium on ‘the micro biome and auto immune disease’ – a relatively new concept which explores the complex relationship between the vast amount of bacteria that inhabit the human body and their interaction with our genes and immune system.
Dr Edoardo Zinicola, Consultant Ophthalmologist at Moorfields, will moderate the Retina session and also present on Central Retinal Vein Occlusion.
Dr Qasiem Nasser, Consultant Ophthalmic Surgeon and Oculoplastics Specialist at Moorfields, will speak about the oculoplastic surgical evaluation of the upper eyelid.
According to Dr Nasser, the most common procedure in facial cosmetic surgery is performed on the upper and lower eyelids – ‘blepharoplasty’. Around 250,000 procedures are performed every year around the world. However, whilst it is a common procedure, the results can vary significantly from patient expectations. “Traditional Blepharoplasty has an enormous potential for disaster. There is no perfect aesthetic procedure and it is very much a case of understanding each patient’s exact problem and addressing it accordingly.”

Moorfields Eye Hospital Dubai invests in the world’s most advanced, fastest fine beam laser eye correction technology

[:en]15 December 2013 (Dubai, United Arab Emirates): Moorfields Eye Hospital Dubai, the first overseas branch of the world renowned Moorfields Eye Hospital in London, has invested in the most advanced technology used for laser refractive surgery for vision correction, providing improved performance for patients in terms of speed, precision, safety and comfort, and often allowing faster visual recovery. Patients can also benefit from a special offer on vision correction surgery until the end of the year. The Schwind Amaris 750S uses an exceptionally small diameter laser beam with a customised ablation map, which matches the shape of the patient’s cornea. The resulting vision for the patient can be an improvement on pre-treatment eyesight with glasses or contact lenses. Moorfields, in Dubai, is among the first private hospitals in the Middle East to invest in the new technology. The Schwind Amaris 750S is the leading technology for laser treatment and operates with a very fast repetition rate: 750 tiny light flashes per second shape the corneal surface quickly resulting in patient comfort and better vision correction, correcting one dioptre (a measure of the optical power of a lens) of myopia within 1.5 seconds, and eight dioptres are removed within 13 seconds.
Dr Edmondo Borasio, Consultant Corneal and Refractive Surgeon at Moorfields Eye Hospital Dubai, said: “Patients should only have this eye correction treatment done once and so they want to have the safest and most effective treatment. The Amaris 750S really is the state of the art in laser vision correction – very fast and accurate, whilst providing information of the cornea on screen in real time. It is especially valuable for patients who have complications from other eye diseases and for those who have a complication following previous surgery. Moorfields is a referral centre for the management of complications following previous refractive surgery. The new technology, which is very compact and patient friendly, is already operational and the patient results have been very good.”
Clinical studies have documented the treatment quality achieved with the Schwind Amaris technology, with visual acuity of 10/10 (100 percent) or better achieved in nearly all cases. This means that a high percentage of treated patients could see even better than before treatment with their glasses or contact lenses. The study also shows that patients had improved contrast vision.
The Schwind Amaris 750S has two energy levels, a high energy level rapidly removes around 80 percent of the tissue to be removed and then a gentler beam removes the remaining 20 percent, creating the smooth surface required for improved vision. Since the patient’s eyes can involuntarily move for milliseconds while fixating on the laser light, the Schwind Amaris 750S compensates for this with its advanced 6 dimensions eye tracker that monitors the position of the eye with approximately 1050 measurements per second and detects all these eye movements and compensates for them, instantly.
Moorfields is currently offering patients (minimum age 21) a saving of up to AED2,500 on vision correction surgery – subject to terms, an initial assessment and the treatment administered – until 31st December 2013.

Moorfields Eye Hospital Dubai and THE VISION CARE INSTITUTE® of Johnson & Johnson collaborate on a professional seminar for the region’s opticians

[:en]9 February 2014 (Dubai, United Arab Emirates): Leadingeye experts from Moorfields Eye Hospital Dubai (Moorfields) presented a professional seminar recently for 26 eye care professionals from across the GCC, organised and hosted by THE VISION CARE INSTITUTE® (The Institute) at Dubai Health Care City. The seminar focused on common conditions and patient questions and concerns around glaucoma – the second leading cause of blindness in the world – and oculoplastics (cosmetic surgery around the eyes).
During the seminar, Consultant Ophthalmic Surgeon and Oculoplastics Specialist at Moorfields Dubai, Dr Qasiem Nasser, discussed the evaluation of the upper eyelid from an oculoplastic perspective in response to the common patient complaint of ‘droopy eyelids’. Eye specialists especially are well equipped to undertake cosmetic procedures around the eyes because of their background knowledge in the specific area of the eye solely and exclusively.
Dr Sohaib Mustafa, Consultant Ophthalmic Surgeon and Glaucoma Specialist at Moorfields Dubai, then covered Glaucoma,discussing the detection, referral and management of the disease. Glaucoma is the second leading cause of blindness worldwide and the number one cause of irreversible blindness. However, the disease is treatable and blindness can be prevented through early diagnosis. Although children and young adults can be affected by Glaucoma, high risk groups include older` people (with an increasing risk over 40 years ofage), uncontrolled diabetics and those with a family history of glaucoma. The World Health Authority estimates that Glaucoma affects around 60 million people globally. Glaucoma is called “the sneak thief of sight” because there are no symptoms and once vision is lost, it is permanent. As much as 40 percent of vision can be lost without a person noticing.
Commenting on the seminar, Dr Clare Roberts, Medical Director at Moorfields Eye Hospital Dubai, said: “Training – alongside research and treatment – is an integral part of the Moorfields mission in the region and we are delighted to be working alongside THE VISION CARE INSTITUTE® which shares inour commitment to a patient-led approach to continual medical education. The Institute provides world class training facilities and resources, dedicated to improving the professional standards of eye care professionals in the region. By focusing on frontline eye care professionals, we can make a real difference to theirpatients by helping them identify potential problems even before there are any symptoms. Glaucoma is a great example – screening for the disease and then compliance with the treatment regime are two importantmessages for the professional community to share with their patients.”
THE VISION CARE INSTITUTE® in Dubai Health Care City, Dubai, offers continual education to eye care professionals all over the Middle East, with the aim of fostering a more confident and proactive approach to eye care. The Institute has state of the art facilities and technology to deliver innovative eye care education and has welcomed over 5,000 delegates since opening in the Middle East in 2008.Type your content here…

Eye experts raise concerns about cataracts as age and diabetes raise threat levels in the region

[:en]30 June 2014 (Dubai, United Arab Emirates): According to the World Health Organisation (WHO), cataracts are the leading cause of blindness and visual impairment in the world (47.9%) and their prevalence increases each year as the world’s population ages. Eye experts at Moorfields Eye Hospital Dubai are warning about the rising incidence of cataracts in the GCC’s young but ageing population (over 65 segment growing from 1.2% in 2015 to 14.2% of the GCC population by 2050) and especially amongst the large diabetic community in the GCC, where the risk of cataracts is much higher. Age and diabetes are the two main risk factors for cataracts.
Cataracts cause gradual blurring of the vision. In 2002, cataracts caused reversible blindness in more than 17 million of the 37 million blind individuals worldwide; this figure is projected to reach 40 million by 2020. In the Gulf region, an ageing population and high incidence of diabetes is raising concerns among eye experts.
‘Cataract’ is an English word for a large waterfall and is also a very apt term used to describe a gradual loss of vision as the lens of the eye becomes opaque and so is like looking through a waterfall. Cataracts are cloudy opacifications of the lens of the eye that interfere with vision. Cataracts can be caused by a wide variety of factors. The lens of the eye is made up of cells that contain protein and with increasing age and after damage to the lens cells by trauma, illness or certain medications over time the protein becomes denser and the lens may start to cloud over.Age is the single most important risk factor for cataracts, which are rare before the age of 40 – although babies can also be born with cataracts. Diabetes is one of the other key factors that result in the development of cataracts; people with diabetes mellitus statistically face a 60% greater risk of developing cataracts.
As with most complications of diabetes, maintaining good control of blood sugar levels will help to reduce risk. Research has shown that people with type 2 diabetes who lower their HbA1c level by just 1% can reduce their risk of cataracts by 19%.Dr Edoardo Zinicola, Consultant Vitreoretinal Surgeon and Medical Retina Specialist at Moorfields Eye Hospital Dubai, the first overseas branch of the world’s largest eye hospital, comments: “We cannot turn back time and even the young population of the Middle East will eventually age, potentially creating a wave of chronic disease – principally diabetes, which will create this perfect storm for cataracts and other serious eye complications. Cataracts generally develop and progress slowly and can eventually lead to significant vision problems. The good news is that cataracts can be treated very effectively with modern surgery to remove the cloudy lens and insert a high quality lens implant. Once treated, cataracts do not return.”
Moorfields is inviting the community and people with diabetes for cataract screening, diagnosis and assessment, as well as surgery where appropriate, and is offering special rates during the summer months.

Moorfields Eye Hospital Dubai gifts eye surgery to 2-year old baby from Nigeria

[:en]6 July 2014 (Dubai, United Arab Emirates): It was the perfect birthday gift – Adetutu spent her second birthday with her mother at Moorfields Eye Hospital Dubai for a follow up consultation with a specialist consultant, following successful surgery to implant intraocular lenses. The case was treated as a charitable case and treatment was offered to Adetutu free of any charge to the family by the hospital, which also collected funds to help meet the costs of accommodation in Dubai and flights to Nigeria. In her short life, Adetutu has also undergone heart surgery in India. Since the surgery in Dubai, Adetutu and her mother have returned safely to Nigeria.
An intraocular lens (IOL) is a lens implanted in the eye used to treat cataracts or secondary aphakia and is the most commonly performed eye surgical procedure.
Speaking about the IOL treatment, Dr Darakhshanda Khurram, Consultant Paediatric Ophthalmologist at Moorfields Eye Hospital Dubai, who performed the surgery, said: “Adetutu and her mother originally came to the hospital to see if we could fit contact lenses but they did not have the funds to do this, as the baby had also needed heart surgery in India, as well. So, we all agreed that we would perform the IOL implants surgery as a charity case with no charge. We are all delighted that the treatment was successful and that we were able to help a baby girl who has been through so much, at such a young age, and to help the struggling mother.”

Speaking at the hospital, the mother of Adetutu, Gwen Adejola, said: “The care has been very special and I hope that Adetutu will be able to see clearly and run around with clear vision. I was extremely surprised and grateful to the staff at Moorfields for the treatment and for the very pleasant and homely environment that we enjoyed.”
On her return to Nigeria, Gwen Adejola composed a poem in appreciation of all the staff at Moorfields:When one is alone lost in the multitude of worries, thinking there is no solution to our problems, then hope and care comes from afar, from places least expected, this great thing you have done, without prejudice, without thinking about colour or class, bringing joys to our lives. At Moorfields, you gave us light to see, for this may your sun never dim, your sun will never dim.

Moorfields Eye Hospital Dubai organizes Glaucoma Symposium to brief UAE specialists on latest advances and risks to people with diabetes

[:en]17 November 2014 (Dubai, United Arab Emirates): Moorfields Eye Hospital Dubai, supported by the Emirates Medical Association Ophthalmic Society, has organized a Glaucoma Symposium for specialists from across the UAE to brief them on the latest developments in the diagnosis and treatment of the eye disease. Glaucoma generally affects older people but uncontrolled diabetes is also a major risk factor, making Glaucoma a health issue even for the relatively young population of the UAE.
The World Health Authority estimates that Glaucoma affects around 60 million people globally. Glaucoma is the second leading cause of blindness worldwide and the number one cause of irreversible blindness. There is no cure, however, the disease is treatable and blindness can be prevented through early diagnosis, highlighting the importance of screening.
At the Glaucoma Symposium, expert speakers from four leading eye hospitals and clinics in Abu Dhabi and Dubai took the group of UAE ophthalmologists through the various forms of the disease and the latest in medications and surgical techniques, during the half-day session at the Al Bustan Rotana Hotel in Dubai on Friday 7th November. The symposium attracted more than 100 delegates to the CME (Continuing Medical Education) accredited event.
Glaucoma is a group of eye diseases that cause progressive damage of the optic nerve. If left untreated, most types of glaucoma result (without warning or obvious symptoms to the patient) in increasing visual damage and may lead to blindness. Once this has happened, the visual damage is permanent, which is why glaucoma is described as the “silent blinding disease” or the “sneak thief of sight”.
According to the World Health Organization, the number of people estimated to be blind as a result of primary glaucoma is 4.5 million, accounting for slightly more than 12 per cent of all global blindness. The incidence of some types of Glaucoma rises with age and its progression is more frequent in people of African origin. Although children and young adults can be affected by Glaucoma, high risk groups include older people (with an increasing risk over 40 years of age), uncontrolled diabetics and those with a family history of Glaucoma.
Speaking on the sidelines of the Glaucoma Symposium, where he was a principal speaker, Dr Mohammed Sohaib Mustafa, Consultant Glaucoma Surgeon at Moorfields Eye Hospital Dubai, commented: “Glaucoma has no symptoms in its early stages and up to 40 per cent loss of sight can occur before any problem is noticed by the sufferer. This is why we wanted to bring together eye care professionals in the UAE for this Glaucoma Symposium. We are advising the community in Dubai – and especially people with diabetes and anyone over the age of 40 – to undertake regular screening every year. It really could save your eyesight. We have a relatively young population in the UAE but with a high incidence of diabetes and so, as the population ages, there is the risk of an increase of Glaucoma.”
Glaucoma is treated with eye drops or surgery (conventional or laser) which can halt or slow-down the disease and further vision loss. Research aims to uncover the mechanisms for the improper levels of intra-ocular pressure, nerve damage and the role of genes. Early detection is essential to limiting visual impairment and preventing the progression towards severe visual handicap or blindness. Screening for Glaucoma involves a mandatory eye pressure check, evaluation of the optic nerve at the back of the eye by a specialist doctor and visualfields test if any changes are seen at the previous exams. All tests are pain free and easy to assess the disease when performed in proper ophthalmic hospitals or clinics. Screening should be done every 12 months.

Moorfields Eye Hospital Dubai supports Dubai Healthcare City’s ‘World Diabetes Day campaign’, a public health screening event offering more than 10 tests for children and adults

[:en]Vision experts will provide complimentary consultations to explain some of the most common and serious complications of diabetes
12 November 2014 (Dubai, United Arab Emirates): To mark World Diabetes Day 2014, Moorfields Eye Hospital Dubai will support Dubai Healthcare City’s public health screening campaign aimed to educate the community about diabetes through consultations and health checks.
The event, organized by DHCC, the world’s largest healthcare free zone, will take place on Thursday, November 13, 4pm-8pm, at The Executive Towers, Business Bay, Dubai. A team from the hospital will provide residents seeking consultations with medical history review, intra-ocular pressure tests, visual acuity checks, and retinal imaging. The vision tests will use state-of-the-art technology.
Retinal diseases, such as diabetic retinopathy, are some of the most common complications caused by diabetes and can lead to permanent loss of vision if not treated. To help the UAE’s large population of people with diabetes manage the disease, Moorfields has established a specialist team of three retinal consultant surgeons and ophthalmologists in Dubai focusing on medical retinal diseases, such as diabetes. Dr. Avinash Gurbaxani, Consultant Ophthalmic Surgeon at Moorfields Eye Hospital Dubai, comments: “Vision-related problems are some of the most common and serious complications of diabetes. Of course, the single most effective treatment for diabetic eye disease is prevention – good control of diabetes and any associated high blood pressure can delay or avoid significant eye problems. Prevention of diabetic eye disease starts with regular eye examinations which can so often provide an indicator of the diabetes or blood pressure control. Regular screening should begin from an early age, regardless of whether there are vision symptoms or not.”
Diabetic retinopathy
Every cell in the eye (and, indeed, the body) is affected by the biochemical changes of diabetes. In practice, however, retinopathy is a disease of blood vessels – sometimes they wither away, sometimes they leak fluids when they shouldn’t and sometimes they grow where they do not belong. The blood vessels in the retina are uniquely prone to going wrong in this way, although the same changes can be found elsewhere in the body.
Treating diabetic retinopathy
According to Dr Edoardo Zinicola, Consultant Vitreoretinal Surgeon and Medical Retina Specialist at Moorfields Eye Hospital Dubai, once retinopathy is present, direct eye treatment may be needed and the type of treatment depends on the problem. “There is no effective treatment for the parts of the retina where blood vessels have disappeared,” he comments. “Laser photocoagulation remains the first line of treatment for both new and leaking vessels. Injections of steroids and medicines known as VEGF blocking agents also have a role and where the eye disease is advanced then surgery can help.”
Prevention tips for patients at risk of diabetic retinopathy

  • Control the diabetes as well as you can
  • Control high blood pressure
  • Do not smoke
  • Get regular eye checks
  • Take charge of your own health

The Moorfields Eye Hospital Dubai specialist team of retinal consultant surgeons and ophthalmologists comprises: Dr Avinash Gurbaxani; Dr Edoardo Zinicola; Dr Jana Sheqem.

Dr. Muralidharan Upendran

[:en]MBBS, MS (Ophth), MRCOphth, FRCOphth
Consultant Ophthalmologist
Vitreo-Retinal Surgeon
GCAA Approved Specialist Medical Examiner]Dr. Muralidharan Upendran is a Consultant Ophthalmologist with sub-specialist training in Vitreo-Retinal surgery. He specialises in the surgical management of retinal disorders including retinal detachment, macular disease, diabetic retinopathy and ocular trauma. He also specializes in the medical management of retinal vascular disease and macular disorders. He is also an experienced cataract surgeon and can manage complex cataract surgery.
Dr. Upendran obtained his medical degree and a basic ophthalmology degree in India. He then moved to the UK where he received further higher specialty training in Ophthalmology in Belfast before becoming a Fellow of the Royal College of Ophthalmologists, London. He received his initial Vitreo-Retinal surgical training at the Royal Victoria Hospital in Belfast. He then received his fellowship training in Vitreo-Retinal surgery at the Birmingham & Midland Eye Centre, UK. He has recently worked as a Consultant Ophthalmologist with a special interest in retinal disease at the Royal Victoria Hospital and Macular Service in Belfast.
Dr. Upendran has an interest in research and teaching. He has a portfolio of published research and has delivered scientific presentations to his peers. He has been involved in teaching programs for medical students. He is a fellow of the Royal College of Ophthalmologists London and a Life member of the All India Ophthalmological Society.
Click here to read more on Common Eye Conditions.
Return to Ophthalmologisits Homepage[:ar]بكالوريوس في الطب والجراحة، ماجستير في
طب العيون
عضو الكلية الملكية لأطباء العيون، زميل الكلية
الملكية لأطباء العيون
استشاري طب العيون
أخصائي في جراحة الشبكية والجسم الزجاجي
أخصائي فحص عيون معتمد من الهيئة العامة للطيران المدني]

لدكتور مواليداران أوبندران استشاري في طب العيون باختصاص فرعي في مجال جراحة الشبكية والجسم الزجاجي. ويختص الدكتور أوبندران في الإدارة الجراحية لاضطرابات الشبكية بما في ذلك انفصال الشبكية ومرض الضمور البقعي واعتلال الشبكية الناجم عن مشاكل السكري وإصابات العين. كما يتخصص في علاج وإدارة أمراض الأوعية الدموية بالشبكية واضطرابات الضمور البقعي، وله خبرة واسعة في جراحة إعتام عدسة العين ومؤهل لتنفيذ الجراحات المعقدة في هذا المجال.درس الدكتور أوبندران الطب والاختصاص الأساسي في طب العيون في الهند، وانتقل بعدها إلى المملكة المتحدة حيث تلقى تدريباً متخصصاً في طب العيون في بيلفاست، قبل أن يحصل على زمالة الكلية الملكية لأطباء العيون في لندن. وفيما بدأ تدريبه الأولي في مجال جراحة الشبكية والجسم الزجاجي في مستشفى رويال فيكتوريا في بيلفاست، فقد واصل رحلته في هذا المجال وحصل على تدريب الزمالة في جراحة الشبكية والجسم الزجاجي من مركز بيرمنغهام وميدلاند للعيون بالمملكة المتحدة. عمل الدكتور أوبندران مؤخراً ك أخصائي في طب العيون مع التركيز على أمراض الشبكية لدى مستشفى رويال فيكتوريا وقسم أمراض الضمور البقعي في بيلفاست.
تشمل اهتمامات الدكتور أوبندران أيضاً مجالات الأبحاث والتدريس، ونشرت له مجموعة من الأبحاث كما قدم العديد من الأوراق العلمية في مؤتمرات متخصصة وشارك في برامج تعليمية موجهة لطلاب كليات الطب، يذكر أن (AIOS) الدكتورأوبندران زميل الكلية الملكية لأطباء العيون في لندن وعضو مدى الحياة في جمعية طب العيون لعموم الهند.
انقر هنا لقراءة المزيد عن حالات العين الشائعة
العودة إلى صفحة أطباء العيون

[:]

Dr. Osama Giledi

[:en]]MBBch, FRCSEd
Consultant Ophthalmologist
Specialist in Cataract, Cornea and Refractive Vision Correction Surgery
GCAA Approved Specialist Aeromedical Medical Examiner
Associate Professor of Ophthalmology (Adjunct) Dr Osama Giledi is a highly experienced consultant ophthalmologist who specialises in Cornea, Anterior Segment, Cataract and Refractive Surgery. He is also skilled in managing ocular surface problems including severe dry eye and Stem cell deficiency.  He performs small incision phacoemulsification for his cataract surgery and is experienced in using toric and multifocal premium intraocular lenses. Dr Giledi expertise in managing complex corneal conditions includes all types of modern corneal graft procedures, such as DALK and DSAEK. He has performed more than 23,000 refractive surgeries including Lasik, LASEK, Intralase LASIK and Trans PRK, as well as phakic IOLs. He delivers the latest treatment for keratoconus including Intracorneal ring segments, corneal cross-linking and complex laser treatment.
Dr Giledi graduated from Libya and completed his ophthalmic training in the UK, attaining a Fellowship in Ophthalmology from The Royal College of Edinburgh in 1996. He completed 2 years of higher subspecialty training fellowship on the anterior segment, Cornea and refractive surgery on 2003 at the prestigeous Corneoplastic Unit and Eye Bank at Queen Victoria Hospital, East Grinstead. He worked as a Consultant Ophthalmologist at the Centre for Sight London and also at the Corneoplastic Unit and Eye Bank at Queen Victoria Hospital.  Dr Giledi relocated to Dubai on 2013 after 22 years’ experience in the UK, providing anterior segment, Cornea, Refractive and cataract surgery services.
In addition to his clinical commitments, Dr. Giledi has extensive experience in teaching and training, he is a noted presenter at national and international meetings, and he has an extensive body of research published in peer-reviewed scientific journals. He is a member of the Royal College Surgeons of Edinburgh, the United Kingdom & Ireland Society of Cataract and Refractive Surgeons, and the European Society of Cataract and Refractive Surgeons.
Click here to read more on Common Eye Conditions.
Return to Ophthalmologisits Homepage[:ar]بكالوريوس في الطب والجراحة
زميل الكلية الملكية البريطانية للجراحين
استشاري طب العيون
أخصائي جراحة الكتاراكت والقرنية وتصحيح البصر
أخصائي فحص عيون معتمد من الهيئة العامة للطيران المدني
استاذ مشارك في طب العيون (ملحق)الدكتور أسامة الجليدي هو استشاري في طب العيون ويملك خبرة واسعة في مجالات جراحة القرنية والجزء الأمامي من العين وعلاج إعتام عدسة العين وجراحة تصحيح البصر. وهو أيضاً خبير في علاج مشاكل سطح العين، بما في ذلك جفاف العين الشديد ونقص الخلايا الجذعية. وتشمل خبرته إزالة إعتام عدسة العين بتقنية استحلاب عدسة العين أو phacoemulsification” “، بالإضافة استخدام العدسات المحدبة والعدسات الفائقة متعددة البؤر. يملك الدكتور الجليدي خبرة واسعة في تشخيص وعلاج مشاكل القرنية المعقدة، بما في ذلك إجراء عمليات زراعة القرنية الحديثة مثل زراعة القرنية الأمامية العميقة (DALK) و الزراعة الداخلية لخلايا القرنية (DSAEK). أجرى ما يزيد على 23,000 جراحة لتصحيح البصر بما في ذلك عمليات التصحيح بالليزر LASIK وLASEK وIntraLase LASIK وTrans PRK، إلى جانب زراعة عدسات العين (Phakic IOLs). ينفذ د. الجليدي أيضًا أحدث الأساليب لعلاج القرنية المخروطية، بما في ذلك الحلقات القرنية وتصليب القرنية والعلاج المعقد بالليزر.
تخرج الدكتور الجليدي في ليبيا وأنهى تخصصه في طب العيون في المملكة المتحدة، حيث حاز على زمالة طب العيون من الكلية الملكية بإدنبره سنة 1996. وفي عام 2003 أنهى عامين من متطلبات تدريب الزمالة في تخصص فرعي لجراحة الجزء الأمامي للعين والقرنية وجراحة تصحيح البصر، وذلك في وحدة الجراحة التجميلية للقرنية وبنك العيون في مستشفى الملكة فيكتوريا في إيست غرينستيد. شغل منصب استشاري طب العيون في مركز البصر بلندن وكذلك في في وحدة الجراحة التجميلية للقرنية وبنك العيون في مستشفى الملكة فيكتوريا. وانتقل الدكتور الجليدي إلى دبي في عام 2013 بعد خبرة 22 عامًا في المملكة المتحدة، ويجري حاليًا جراحات الجزء الأمامي للعين والقرنية وتصحيح البصر وإعتام عدسة العين.
وبالإضافة إلى مجال اختصاصه، يتمتع الدكتور أسامة الجليدي بخبرة واسعة في مجال التدريس والتدريب، كما يشارك كمتحدث في العديد من اللقاءات المحلية والدولية وله أبحاث ومؤلفات في مجلات طبية مرموقة. وهو عضو في الكلية الملكية للجراحين في إدنبرة، وفي جمعية المملكة المتحدة وإيرلندا لجراحي إعتام عدسة العين وتصحيح البصر، وفي الجمعية الأوروبية لجراحي إعتام عدسة العين وتصحيح البصر.
انقر  هنا لقراءة المزيد عن حالات العين الشائعة
العودة إلى صفحة أطباء العيون[:]